-
BASF Venture Capital invests in Canadiancompany Quantiam Technologies Inc.Investment of €2 million with the main focus on catalytically active coatings for steam cracker furnace tubes Ludwigshafen , Germany – February 4, 2010 – BASF Venture Capital GmbH, Ludwigshafen, i2010/2/9
-
Avexa Announces Positive HIV Therapy TrialsAustralia's Avexa has announced positive results from a Phase III study of apricitabine (ATC), a new therapy to treat patients with HIV. The Phase III trial compared ATC to 3TC in drug-resistant HI2010/2/8
-
Shire Applies For Fabry Drug Licensing in USShire has submitted a Biologics License Application to the US Food and Drug Administration (FDA) for Replagal, an enzyme replacement therapy for Fabry disease. Replagal first received marketing aut2010/2/8
-
BASF and Embrapa’s Cultivance®soybeans receive approval for commercial cultivation in BrazilFirst genetically modified crop developed in Brazil to reach commercialization stage Market launch to take place after regulatory approval in key export markets Brasília and São Paulo Braz2010/2/8
-
The Third General Assembly of the Ninth Chinese Pharmacopoeia Commission and the Summing-up Conference on Compilation of 2010 Chinese Pharmacopoeia held in BeijingOn February 1, 2010, The Third General Assembly of the Ninth Chinese Pharmacopoeia Commission and the Summing-up Conference on Compilation of Chinese Pharmacopoeia (2010 Edition) was held in B2010/2/5
-
BASF raises prices for ethanolamines, ethyleneamines and isopropanolamines in EuropeWith immediate effect, BASF is increasing the sales prices for ethanolamines, ethyleneamines and isopropanolamines in Europe as follows, existing contracts permitting: Ethanolamines: Mon2010/2/5
-
Preserving Europe’s prosperity through innovationAs the national champion of a group of European business leaders, BASF’s boss Dr. Jürgen Hambrecht has spoken up for Europe. “We need to combine our strengths and focus on the sole opportunity that we2010/2/5
-
Assay Development for Immunogenicity Testing of herapeutic Proteins20100204(3).rar2010/2/4
-
Compounding Tamiflu OralSuspension in Advance to Provide for Multiple Prescriptions20100204(2).rar2010/2/4
-
The Use of Mechanical Calibration of Dissolution Apparatus 1 and 2 – Current Good Manufacturing Practice20100204(1).rar2010/2/4